A Feasibility Study of Bezafibrate in Mitochondrial Myopathy
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Bezafibrate (Primary)
- Indications Mitochondrial myopathies
- Focus Therapeutic Use
- 29 Mar 2017 Planned End Date changed from 1 Jul 2016 to 1 Aug 2017.
- 29 Mar 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Aug 2017.
- 08 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTtials.gov.